Effects of prediabetes on coronary collateral circulation in patients with coronary artery disease

Coronary Artery Disease

Volumn 22, Issue 4, 2011, Pages 233-237

  Kadi, Hasan ^a   Ceyhan, Koksal ^a   Karayakali, Metin ^a   Celik, Atac ^a   Ozturk, Ahmet ^a   Koc, Fatih ^a   Onalan, Orhan ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Collateral circulation; coronary artery disease; prediabetes

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; RETROSPECTIVE STUDIES;

EID: 79955587967     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328345241b     Document Type: Article

References (26)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008 (Suppl 1):S55-S60.
2. Stratton IM, Adler AI, Neil HA, Matthew R, Manley SE, Cull A, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 321:405-412. (Pubitemid 30609442)
3. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95783 individuals followed for 12.4 years. Diabetes Care 1999; 22:233-240. (Pubitemid 29056916)
4. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian diabetes, obesity, and lifestyle study (AusDiab). Circulation 2007; 116:151-157. (Pubitemid 47057520)
5. Weihrauch D, Lohr NL, Mraovic B, Ludwig LM, Chilian WM, Pagel PS, et al. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation 2004; 109:2343-2348. (Pubitemid 38656871)
6. Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B, et al. Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome. Am J Cardiol 2006; 97:636-639. (Pubitemid 43255030)
7. Mouquet F, Cuilleret F, Susen S, Sautié re K, Marboeuf P, Ennezat PV, et al. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: Association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1. Eur Heart J 2009; 30:840-849.
8. Levin DC. Pathways and functional significance of the coronary collateral circulation. Circulation 1974; 50:831-837.
9. Elayda MA, Mather VS, Hall RJ, Massumi GA, Garcia E, De Castro CM. Collateral circulation in coronary artery disease. Am J Cardiol 1985; 55:58-60. (Pubitemid 15152522)
10. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development: Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38:1872-1878. (Pubitemid 33116557)
11. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral filling immediately after controlled coronary artery occlusion by an angioplasty baloon in human. J Am Coll Cardiol 1985; 5:587-592. (Pubitemid 15141963)
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
13. Van Golde JM, Ruiter MS, Schaper NC, Vö ö S,Waltenberger J, Backes WH, et al. Impaired collateral recruitment and outward remodeling in experimental diabetes. Diabetes 2008; 57:2818-2823.
14. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, et al. Effect of DM on formation of coronary collateral vessels. Circulation 1999; 99:2239-2242. (Pubitemid 29201128)
15. Choi EK, Kim HS, Park KW, Kim HK, Cho JW, Lee MM, et al. Novel index of coronary collateral development as a useful predictor of clinical outcome in type 2 diabetic patients with coronary artery disease. Circ J 2005; 69:786-792.
16. Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, et al. Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 2004; 53:2383-2391. (Pubitemid 39145593)
17. Kilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: Determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002; 13:155-159. (Pubitemid 34747963)
18. Melidonis A, Tournis S, Kouvaras G, Baltaretsou E, Hadanis S, Hajissavas I, et al. Comparison of coronary collateral circulation in diabetic and non-diabetic patients suffering from coronary artery disease. Clin Cardiol 1999; 22:465-471. (Pubitemid 29302756)
19. Werner G, Richartz B, Heinke S, Ferrari M, Figulla HR. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 2003; 24:1134-1142. (Pubitemid 36723579)
20. Zbinden R, Zbinden S, Billinger M,Windecker S, Meier B, Seiler C. Influence of diabetes mellitus on coronary collateral flow: An answer to an old controversy. Heart 2005; 91:1289-1293. (Pubitemid 41360943)
21. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med 2000; 342:1040-1042. (Pubitemid 30180652)
22. Turhan H, Yasar AS, Erbay AR, Yetkin E, Sasmaz H, Sabah I. Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis 2005; 16:281-285. (Pubitemid 41073296)
23. Sasmaz H, Yilmaz MB. Coronary collaterals in obese patients: Impact of metabolic syndrome. Angiology 2009; 60:164-168.
24. Matsunaga T, Weihrauch DW, Moniz MC, Tessmer J, Warltier DC, Chilian WM. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation 2002; 105:2185-2191. (Pubitemid 34517163)
25. Honing ML, Morrison PJ, Banga JD, Stroes ES, Rabeling TJ. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998; 14:241-249. (Pubitemid 28499613)
26. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94:2036-2044. (Pubitemid 24348244)